BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36566878)

  • 1. PTPN11 Mosaicism Causes a Spectrum of Pigmentary and Vascular Neurocutaneous Disorders and Predisposes to Melanoma.
    Polubothu S; Bender N; Muthiah S; Zecchin D; Demetriou C; Martin SB; Malhotra S; Travnickova J; Zeng Z; Böhm M; Barbarot S; Cottrell C; Davies O; Baselga E; Burrows NP; Carmignac V; Diaz JS; Fink C; Haenssle HA; Happle R; Harland M; Majerowski J; Vabres P; Vincent M; Newton-Bishop JA; Bishop DT; Siegel D; Patton EE; Topf M; Rajan N; Drolet B; Kinsler VA
    J Invest Dermatol; 2023 Jun; 143(6):1042-1051.e3. PubMed ID: 36566878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correspondence Concerning PTPN11 Mosaicism Causes a Spectrum of Pigmentary and Vascular Neurocutaneous Disorders and Predisposes to Melanoma.
    Torchia D
    J Invest Dermatol; 2023 Dec; 143(12):2536-2537. PubMed ID: 37236594
    [No Abstract]   [Full Text] [Related]  

  • 3. Mosaic Neurocutaneous Disorders and Their Causes.
    Ruggieri M; Praticò AD
    Semin Pediatr Neurol; 2015 Dec; 22(4):207-33. PubMed ID: 26706010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to phacomatoses (neurocutaneous disorders) in childhood.
    Ruggieri M; Polizzi A; Marceca GP; Catanzaro S; Praticò AD; Di Rocco C
    Childs Nerv Syst; 2020 Oct; 36(10):2229-2268. PubMed ID: 32940773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papular nevus spilus syndrome: old and new aspects of a mosaic RASopathy.
    Torchia D; Happle R
    Eur J Dermatol; 2019 Feb; 29(1):2-5. PubMed ID: 30827948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phakomatosis pigmentovascularis cesioflammea: a case report].
    Viada Peláez MC; Stefano PC; Cirio A; Cervini AB
    Arch Argent Pediatr; 2018 Feb; 116(1):e121-e124. PubMed ID: 29333836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular manifestations in phakomatosis pigmentovascularis: Current concepts on pathogenesis, diagnosis, and management.
    Abdolrahimzadeh S; Pugi DM; de Paula A; Scuderi G
    Surv Ophthalmol; 2021; 66(3):482-492. PubMed ID: 33058925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis.
    Thomas AC; Zeng Z; Rivière JB; O'Shaughnessy R; Al-Olabi L; St-Onge J; Atherton DJ; Aubert H; Bagazgoitia L; Barbarot S; Bourrat E; Chiaverini C; Chong WK; Duffourd Y; Glover M; Groesser L; Hadj-Rabia S; Hamm H; Happle R; Mushtaq I; Lacour JP; Waelchli R; Wobser M; Vabres P; Patton EE; Kinsler VA
    J Invest Dermatol; 2016 Apr; 136(4):770-778. PubMed ID: 26778290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phacomatosis pigmentovascularis spilorosea and mutation in the PTPN11 gene: new case with significant neurologic impairment.
    Maione V; Soglia S; Miccio L; Calzavara-Pinton P; Napolitano A; Cinquina V; Ritelli M; Colombi M
    J Dtsch Dermatol Ges; 2022 Aug; 20(8):1133-1136. PubMed ID: 35698861
    [No Abstract]   [Full Text] [Related]  

  • 10. Germline PTPN11 and somatic PIK3CA variant in a boy with megalencephaly-capillary malformation syndrome (MCAP)--pure coincidence?
    Döcker D; Schubach M; Menzel M; Spaich C; Gabriel HD; Zenker M; Bartholdi D; Biskup S
    Eur J Hum Genet; 2015 Mar; 23(3):409-12. PubMed ID: 24939587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound heterozygosity for PTPN11 variants in a subject with Noonan syndrome provides insights into the mechanism of SHP2-related disorders.
    Lorca R; Pannone L; Cuesta-Llavona E; Bocchinfuso G; Rodríguez-Reguero J; Carpentieri G; Hernando I; Flex E; Tartaglia M; Coto E; Gómez J; Martinelli S
    Clin Genet; 2021 Mar; 99(3):457-461. PubMed ID: 33354767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital sensorineural hearing loss as the initial presentation of
    Gao X; Huang SS; Qiu SW; Su Y; Wang WQ; Xu HY; Xu JC; Kang DY; Dai P; Yuan YY
    J Med Genet; 2021 Jul; 58(7):465-474. PubMed ID: 32737134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lateralized overgrowth with vascular malformation caused by a somatic PTPN11 pathogenic variant: Another piece added to the puzzle of mosaic RASopathies.
    Mussa A; Turchiano A; Cardaropoli S; Coppo P; Pantaleo A; Bagnulo R; Ranieri C; Iacoviello M; Garganese A; Stella A; Vallero SG; Bertin D; Santoro F; Carli D; Ferrero GB; Resta N
    Genes Chromosomes Cancer; 2022 Nov; 61(11):689-695. PubMed ID: 35778969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlapping phenotypes between SHORT and Noonan syndromes in patients with PTPN11 pathogenic variants.
    Ranza E; Guimier A; Verloes A; Capri Y; Marques C; Auclair M; Mathieu-Dramard M; Morin G; Thevenon J; Faivre L; Thauvin-Robinet C; Innes AM; Dyment DA; Vigouroux C; Amiel J
    Clin Genet; 2020 Jul; 98(1):10-18. PubMed ID: 32233106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical variability of neurofibromatosis 1: A modifying role of cooccurring PTPN11 variants and atypical brain MRI findings.
    D'Amico A; Rosano C; Pannone L; Pinna V; Assunto A; Motta M; Ugga L; Daniele P; Mandile R; Mariniello L; Siano MA; Santoro C; Piluso G; Martinelli S; Strisciuglio P; De Luca A; Tartaglia M; Melis D
    Clin Genet; 2021 Nov; 100(5):563-572. PubMed ID: 34346503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phacomatosis melanorosea without extracutaneous features: an unusual type of phacomatosis pigmentovascularis.
    Arnold AW; Kleine MU; Happle R
    Eur J Dermatol; 2012; 22(4):473-5. PubMed ID: 22713702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into Noonan/LEOPARD syndrome-related mutants of protein-tyrosine phosphatase SHP2 (PTPN11).
    Qiu W; Wang X; Romanov V; Hutchinson A; Lin A; Ruzanov M; Battaile KP; Pai EF; Neel BG; Chirgadze NY
    BMC Struct Biol; 2014 Mar; 14():10. PubMed ID: 24628801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phakomatosis cesioflammea with late-onset glaucoma and acquired nevus spilus-like lesion - 15 years of follow-up.
    Chiu HH; Chen GS; Wu CS; Ke CL; Cheng ST
    Int J Dermatol; 2009 Apr; 48(4):416-8. PubMed ID: 19335431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and clinical profile of patients referred as Noonan or Noonan-like syndrome in Greece: a cohort of 86 patients.
    Papadopoulos G; Papadopoulou A; Kosma K; Papadimitriou A; Papaevangelou V; Kanaka-Gantenbein C; Bountouvi E; Kitsiou-Tzeli S
    Eur J Pediatr; 2022 Oct; 181(10):3691-3700. PubMed ID: 35904599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phacomatosis pigmentovascularis type IIIb.
    Seckin D; Yucelten D; Aytug A; Demirkesen C
    Int J Dermatol; 2007 Sep; 46(9):960-3. PubMed ID: 17822502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.